Clinical and genomic hallmarks of low PSA secretors in metastatic castration-resistant prostate cancer (mCRPC).

Gustavo Rubio Romero,Alana S. Weinstein,Verena Friedl,Adam Foye,Denise Playdle,Alexis Sabol,Patricia Li,Jiaoti Huang,Felix Y. Feng,Joshua M. Stuart,Eric J. Small,Rahul Aggarwal

Clinical and genomic hallmarks of low PSA secretors in metastatic castration-resistant prostate cancer (mCRPC).

2019

Gustavo Rubio Romero
Alana S. Weinstein
Verena Friedl
Adam Foye
Denise Playdle
Alexis Sabol
Patricia Li
Jiaoti Huang
Felix Y. Feng
Joshua M. Stuart
Eric J. Small
Rahul Aggarwal

5051Background: Metastatic disease burden out of proportion to low serum PSA level is frequently used as a clinical surrogate for the diagnosis of treatment-emergent small cell neuroendocrine prost...

Keywords:

Prostate cancer
Castration
Pathology
Oncology
Medicine
Internal medicine
Disease burden
castration resistant
Cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations